Questions and Controversies in the Clinical Application of Tyrosine Kinase Inhibitors to Treat Patients with Radioiodine-Refractory Differentiated Thyroid Carcinoma: Expert Perspectives.

Verburg, Frederik A; Amthauer, Holger; Binse, Ina; Brink, Ingo; Buck, Andreas; Darr, Andreas; Dierks, Christine; Koch, Christine; König, Ute; Kreissl, Michael C; Luster, Markus; Reuter, Christoph; Scheidhauer, Klemens; Willenberg, Holger Sven; Zielke, Andreas; Schott, Matthias

Verburg, Frederik A; Amthauer, Holger; Binse, Ina; Brink, Ingo; Buck, Andreas; Darr, Andreas; Dierks, Christine; Koch, Christine; König, Ute; Kreissl, Michael C; Luster, Markus; Reuter, Christoph; Scheidhauer, Klemens; Willenberg, Holger Sven; Zielke, Andreas; Schott, Matthias.

Affiliation

Verburg FA; Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany.
Amthauer H; Erasmus Medical Center, Department of Radiology and Nuclear Medicine, Rotterdam, The Netherlands.
Binse I; Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Nuclear Medicine, Berlin, Germany.
Brink I; Department of Nuclear Medicine, University Clinic Essen, Essen, Germany.
Buck A; Department of Medical Diagnostics and Therapy, Ernst von Bergmann Hospital Potsdam, Potsdam, Germany.
Darr A; Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
Dierks C; Department of Nuclear Medicine, University Hospital Jena, Jena, Germany.
Koch C; Department of Medical Oncology, University Hospital Freiburg, Freiburg, Germany.
König U; Department of Gastroenterology, Hepatology, and Endocrinology, University Clinic Frankfurt, Frankfurt Am Main, Germany.
Kreissl MC; Department of Gastroenterology and Endocrinology, University of Göttingen, Göttingen, Germany.
Luster M; Division of Nuclear Medicine, Department of Radiology and Nuclear Medicine, Otto von Guericke University Magdeburg, Magdeburg, Germany.
Reuter C; Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany.
Scheidhauer K; Department of Palliative Care, Hannover Medical School, Hannover, Germany.
Willenberg HS; Interdisclipinary Endocrine Center, Technical University of Munich, Munich, Germany.
Zielke A; Division of Endocrinology and Metabolism, Medical University of Rostock, Rostock, Germany.
Schott M; Department of Endocrine Surgery, Diakonie Klinikum Stuttgart, Stuttgart, Germany.

Horm Metab Res ; 53(3): 149-160, 2021 Mar.

Article de En | MEDLINE | ID: mdl-33652491

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la thyroïde / Inhibiteurs de protéines kinases / Antinéoplasiques Type d'étude: Clinical_trials / Prognostic_studies / Qualitative_research Limites: Humans Langue: En Journal: Horm Metab Res Année: 2021 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Allemagne

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google